|
|
|
|
Small Stocks, Big Money™
|
|
Weekly Newsletter
|
|
|
|
|
|
|
|
60 Degrees Pharma Sees Promising First Result in Tafenoquine Study for Relapsing Babesiosis
60 Degrees Pharmaceuticals (Nasdaq: SXTP) reported that the first patient in its tafenoquine trial for relapsing babesiosis tested negative for infection using the most sensitive FDA-approved blood screening available, marking a key milestone in validating its high cure potential. A Breakthrough Therapy Designation request has been submitted, with a Type B FDA meeting planned for early 2026 to support a future sNDA for this urgently needed treatment in immunosuppressed patients.
|
|
|
|
XORTX Expands Pipeline with Acquisition of Novel Anti-Fibrotic Kidney Drug Program
XORTX Therapeutics (Nasdaq: XRTX) has signed a binding term sheet to acquire VB4-P5, a promising pre-IND renal anti-fibrotic program from Vectus Biosystems, aimed at treating both rare and common forms of progressive kidney disease. Backed by strong preclinical data and broad global patent protection, the novel small molecule enhances XORTX’s strategic focus in addressing a massive unmet need in kidney fibrosis, a key driver in chronic kidney disease affecting over 35 million Americans.
|
|
|
|
|
NioCorp Releases Strong Assay Results from First Pentagon-Funded Drill Hole at Elk Creek Project
NioCorp Developments (Nasdaq: NB) announced promising assay results from the first completed hole of its Pentagon-backed drilling program at the Elk Creek critical minerals project in Nebraska. Key intercepts included high grades of niobium (up to 1.33% Nb₂O₅) and rare earth oxides exceeding 4,000 ppm TREO, supporting the project's robust resource model and advancing efforts toward up to $800M in potential EXIM Bank financing.
|
|
|
|
|
|
|
Baptist Hospital Adopts Good Salt™ Life’s ByoCart™ System to Boost Air and Surface Safety
NDT Pharmaceuticals (OTC: NDTP) announced that Baptist Hospital has implemented its Good Salt™ Life ByoCart™ Disinfection System, enhancing both surface sanitation and air quality across patient care areas. The system’s dual-action air-scrubbing and disinfecting technology ensures consistent, high-efficacy biosafety, marking a key milestone in NDTP’s healthcare market expansion and setting a new standard for hospital-grade infection prevention. Good Salt Life is a wholly owned subsidiary of NDT Pharmaceuticals.
|
|
|
|
|
Jackpot Digital Expands U.S. Footprint with 3-Table Deal at Sevenwinds Casino in Wisconsin
Jackpot Digital (TSXV: JJ | OTCQB: JPOTF) has signed its first Wisconsin agreement, deploying three Jackpot Blitz® dealerless poker tables at Sevenwinds Casino. This expansion underscores rising U.S. demand for the company’s cutting-edge electronic table games, which combine live multiplayer poker with automated efficiency, delivering nonstop action and strong ROI for casino operators.
|
|
|
Recent News
|
RedChip TV
|
|
|
|
RedChip Highlights Nexalin Technology, Inc. (NASDAQ: NXL) & BioVie (NASDAQ: BIVI)
|
|
|
|
|
|
|
|
|
|
Unlock Smarter Investing with RedChat
|
|
|
Tired of sifting through endless filings? Let RedChat do the heavy lifting. Get real-time, data-driven insights on over 2,000 small-cap stocks—instantly. Save time, make informed decisions, and stay ahead of the market.
|
|
Access RedChat now, free of charge.
|
|
|
|
|
Recent Research Coverage Updates
| Company |
Rating |
Price Target |
Firm |
Report Date |
| NioCorp (Nasdaq: NB) |
Buy |
$15 |
Maxim |
October 15, 2025 |
| NioCorp (Nasdaq: NB) |
Buy |
$8 |
H.C. Wainwright |
September 22, 2025 |
| Alliance Entertainment (Nasdaq: AENT) |
Buy |
$11 |
Noble Capital |
October 6, 2025 |
| FibroBiologics (Nasdaq: FBLG) |
Buy |
$4 |
Maxim |
September 22, 2025 |
| XORTX Therapeutics (Nasdaq: XRTX) |
Buy |
$14 |
AGP |
September 18, 2025 |
| FibroBiologics (Nasdaq: FBLG) |
Buy |
$10 |
H.C. Wainwright |
September 12, 2025 |
| Alliance Entertainment (Nasdaq: AENT) |
Buy |
$10 |
Maxim |
September 11, 2025 |
| FibroBiologics (Nasdaq: FBLG) |
Buy |
$16 |
D Boral |
September 10, 2025 |
| Greenwich LifeSciences (Nasdaq: GLSI) |
Buy |
$45 |
Noble |
August 20, 2025 |
| Nexalin Technology (Nasdaq: NXL) |
Buy |
$4 |
Maxim |
August 19, 2025 |
| Atossa Therapeutics (Nasdaq: ATOS) |
Buy |
$7 |
HC Waingwright |
August 12, 2025 |
| Atossa Therapeutics (Nasdaq: ATOS) |
Buy |
$4 |
Maxim |
August 12, 2025 |
| Atossa Therapeutics (Nasdaq: ATOS) |
Buy |
$4 |
Maxim |
August 12, 2025 |
| FibroBiologics (Nasdaq: FBLG) |
Buy |
$16 |
D Boral |
July 29, 2025 |
| Connect Biopharma (Nasdaq: CNTB) |
Buy |
$7.5 |
Northland Securities |
July 23, 2025 |
| Connect Biopharma (Nasdaq: CNTB) |
Buy |
$4 |
Titan Partners |
July 17, 2025 |
| NioCorp (Nasdaq: NB) |
Buy |
$5 |
Maxim |
July 10, 2025 |
| Connect Biopharma (Nasdaq: CNTB) |
Buy |
$7 |
H.C. Wainwright |
July 9, 2025 |
| FibroBiologics (Nasdaq: FBLG) |
Buy |
$16 |
D Boral |
July 9, 2025 |
| NioCorp (Nasdaq: NB) |
Buy |
$4 |
HC Wainwright |
July 2, 2025 |
| Alliance Entertainment (Nasdaq: AENT) |
Buy |
$10 |
Maxim |
July 1, 2025 |
|
|
|
|
|
|
Small Stocks, Big Money™ Podcast
|
|
The podcast features in-depth interviews with CEO's from the top names in small-cap stocks, providing listeners with a unique perspective not found anywhere else.
|
|
Available on:
|
|
|
|
|
|
|
Upcoming Events
|
|
|
60 Degrees Pharmaceuticals (NASDAQ: SXTP)
4:15pm Eastern
60 Degrees Pharmaceuticals (60P) is a growth-oriented biotechnology company with a goal of using cutting-edge biological science and applied research to further develop and commercialize new therapies for the prevention and treatment of infectious diseases.
|
|
|
|
NioCorp Developments (NASDAQ: NB)
4:15pm Eastern
NioCorp is developing the Elk Creek Project that is expected to produce niobium, scandium, and titanium. The Company also is evaluating the potential to produce several rare earths from the Elk Creek Project.
|
|
|
|
ASP Isotopes (NASDAQ: ASPI)
04:15pm Eastern
This exclusive event will provide investors with an opportunity to gain critical insights into ASP Isotopes' strategic initiatives and technological advancements.
|
|
|
|
NASDAQ: NXL - Nexalin Technology
4:15pm Eastern
Nexalin designs and develops innovative neurostimulation products to uniquely help combat the ongoing global mental health epidemic.
|
|
|
|
BullFrog AI (NASDAQ: BFRG)
4:15pm Eastern
BullFrog AI, a US-company headquartered in Maryland, is revolutionizing drug discovery and development with BullFrog Data Networks®, a cutting-edge platform powered by its proprietary bfLEAP® technology.
|
|
|
|
Archived Events
|
|
|
Jackpot Digital (OTCQB: JPOTF)
4:15pm Eastern
Jackpot Digital Inc. is the leading provider of electronic poker table games, offering innovative gaming solutions to casinos worldwide.
|
|
|
|
FatPipe (NASDAQ: FATN)
4:15pm Eastern
FatPipe, Inc. (Nasdaq: FATN) is a pioneer in secure, software-defined networking technologies that simplify and fortify enterprise connectivity.
|
|
|
|
Quote of the Week
|
"Stocks are different from other investments-say, real estate. They're intangibles; we can't live in them or even touch or see them, and so their price depends largely on what the future holds or what it is perceived to hold."
|
|
|
|
|
Order "Small Stocks, Big Money™ Today!
Dave Gentry's new book, Small Stocks, Big Money: Interviews With Microcap Superstars, is now available for pre-order. Published by Wiley Finance, this first-hand perspective and insider information on the fast world of microcap investing is now available for purchase.
|
|
|
|
|
|
|
Lesson of the Week
What's the BETA of the stocks in your portfolio?
|
|
|
|
|
|
|
